<TEXT>&#2;<DATELINE>2011-08-01</DATELINE><TITLE>Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses</TITLE><BODY>Monoclonal antibody technology has undergone rapid and innovative reinvention over the last 30 years. Application of these technologies to human samples revealed valuable therapeutic and experimental insights. These technologies, each with their own benefits and flaws, have proven indispensable for immunological research and in our fight to provide new treatments and improved vaccines for infectious disease.&#3;</BODY></TEXT>